Other

Cullen Thomas Moore

Timothy S Moore

Steven Jerome Moore

Nadimpally Satyavarahala Raju

Nadimpally Neha Varma

Venkata Satya Suresh Attili

Neha Varma Nadimpally

Embodiments include a method of using inactivated human cold coronaviruses (HCoVs) particularly HCoV-299E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1 as a booster, for the immunization against SARS-CoV-2 infections.

HCoV immunogenic booster composition for improving immunityagainst SARS-COV-2 infection

The present invention in an embodiment relates generally to mask/respirator having a filter assembly detachable therefrom.

Bioburden reduction surgical masks/respirators with use in protection against SARS-CoV-2 infections

A method for amelioriation of, or prophylaxis against, a viral infection comprising administering to a patient in need of treatment a therapeutically effective amount of 5 aminolevulinic acid, optionally with at least one of cucumarin nano, zinc, vitamin C and methylene blue, and compositions thereof. Such compositions may be used for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses.

Viral infection treatment with 5-aminolevulinic acid

Embodiments include a method of using inactivated human cold coronaviruses (HCoVs) particularly HCoV-299E, HCoV-OC43, HCoV-NL63 and HCoV-HKU1, alone or as a booster, for the immunization against SARS-CoV-2 infections. Vaccine embodiments further comprise HCoV virus envelope subunits which may be in the form of virus-like spheroids (VLS).

HCoV vaccine for improving immunity against SARS-CoV-2 infection

In embodiments there is described a method for reducing false positives and negatives in the detection of SARS-CoV-2 in suspected patients using mass spectroscopy employing the steps of mixing samples of collected saliva and nasopharyngeal secretions in a single sample container; adding universal transport medium to the mixed samples in said single sample container; transporting the single sample container at a temperature above 0&#xb0; C. to a remote location; deactivation of viral content of the mixed sample; protein digestion of the mixed sample; concomitant separation of peptides, ionization by mass spectroscopy of the separated peptides, and comparison of peptide patterns to known SARS-CoV-2 peptides. Also set forth in an embodiment is a collection container for collecting saliva and/or sputum, as well as a swab member, with universal transport medium and/or virus inactivating agent housed in separate compartment communicable with sample compartment through a one-way valve.

Collection system and device for reducing clinical false positives and negatives in the detection of SARS-CoV-2

Therapy for viral infections including the novel corona virus (COVID-19)

The present invention provides therapeutic combinations of 5-aminolevulinic acid, with at least one of: Vitamin C, curcumin, zinc, and methylene blue for the treatment of coronavirus infections, including the SARS-CoV-2 virus, and/or rhinoviruses. Optionally such compositions may comprise other dietary supplements and one or more pharmaceutically acceptable excipients and also process for preparing it. The composition can also include other antiviral agents.

Combination therapy for coronavirus infections including the novel corona virus (COVID-19)

Method for reducing clinical false positives and negatives in the detection of SARS-CoV-2

The present invention in an embodiment relates generally to an air purifier having an ultraviolet wave chamber which is accessible from the exterior designed for the placement of masks/respirators in need of decontamination. Such device preferably makes use of filters comprising copper foam.

Growing community of inventors

Newtown, CT, United States of America

Cullen Thomas Moore